News
-
-
COMMUNIQUÉ DE PRESSE
Teva becomes secondary commercialization partner for Formycon's Stelara® biosimilar FYB202 (ustekinumab) under the brand name Fymskina® in Germany
Teva partners with Formycon for commercialization of Stelara biosimilar FYB202 (ustekinumab) as Fymskina in Germany. Market launch planned in Q3 2025 -
COMMUNIQUÉ DE PRESSE
XCF Global and Continual Renewable Ventures Announce Memorandum of Understanding to Launch New Rise Australia, a SAF and HVO Platform Powered by XCF
XCF Global and Continual Renewable Ventures aim to establish New Rise Australia as a leading SAF and HVO platform with an exclusive focus on the Australian market. Partnership aligns with international expansion strategy -
-
-
COMMUNIQUÉ DE PRESSE
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
DBV Technologies announces screening of first subject in COMFORT Toddlers safety study for peanut-allergic toddlers aged 1-3. Multiple sites active for subject screenings across U.S. and Canada -
COMMUNIQUÉ DE PRESSE
Discovery Energy Metals Corp. Announces Acquisition of Crystal Lake Copper Property in British Columbia
Discovery Energy Metals Corp. completes acquisition of mineral claims for Crystal Lake Copper Property, advancing domestic energy freedom. Company focuses on mineral resource projects in North America -
COMMUNIQUÉ DE PRESSE
Verve Group SE announces that the total number of shares of the company increases following the issuance of new shares to service parts of the employee stock option program
Verve Group SE increases total shares by issuing new shares for employee stock options. Total shares now 200,099,306. Details on warrants and responsible parties provided -
-
